Axxelera
Pre-clinicalUp to 200,000 tailor-made peptides per array for epitope mapping, affinity studies, biomarker discovery & immunoprofiling.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Up to 200,000 tailor-made peptides per array for epitope mapping, affinity studies, biomarker discovery & immunoprofiling.
OncologyImmunologyCell Therapy